Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Verastem Oncology issued inducement awards to 31 new employees, consisting of 399,750 restricted stock units and 91,000 stock options. The options were granted with an exercise price of $4.10, matching the stock's closing price on July 1, 2026.
Key figures
- Rsus granted
- 399750
- Exercise price
- 4.1
- Options granted shares
- 91000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.